← All news

FROM THE NEWS FEED

Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference

2026-09-30 • Psychedelic Invest

Article summary

NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”), a clinical stage biotechnology company focused on developing…

Continue to the original publication for the complete article.